Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets
Clinical trial NCT02993237 · COMPLETED
Trial details
- NCT number
- NCT02993237
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2017-05-25
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.